L G BekkerM DasQ Abdool KarimK AhmedE et alManjeetha JaggernathLimakatso LebinaThesla Palanee-PhilipsRavindre Panchia2024-12-052024-12-05WOS0028-4793https://hdl.handle.net/10539/43172TwiceYearly Lenacapavir or Daily FTAF for HIV Prevention in Cisgender WomenJournal Article